Literature DB >> 3098704

Chelating agents for the binding of metal ions to antibodies.

C F Meares.   

Abstract

The development and applications of bifunctional chelating agents are reviewed, with emphasis on the preparation of radiolabeled monoclonal antibodies suitable for use in vivo. Major principles and practical aspects of the chemical procedures are outlined, and new results of interest for future work are described.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098704     DOI: 10.1016/0883-2897(86)90003-6

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN: 0883-2897


  5 in total

Review 1.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

2.  Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.

Authors:  In Soo Shin; Sang-Myung Lee; Hyung Sub Kim; Zhengsheng Yao; Celeste Regino; Noriko Sato; Kenneth T Cheng; Raffit Hassan; Melissa F Campo; Earl F Albone; Peter L Choyke; Ira Pastan; Chang H Paik
Journal:  Nucl Med Biol       Date:  2011-07-07       Impact factor: 2.408

Review 3.  The development of copper radiopharmaceuticals for imaging and therapy.

Authors:  Monica Shokeen; Thaddeus J Wadas
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

4.  Radiolabeling of a cyclic RGD (cyclo Arg-Gly-Asp-d-Tyr-Lys) peptide using sodium hypochlorite as an oxidizing agent.

Authors:  Stephanie Doll; Karen Woolum; Krishan Kumar
Journal:  J Labelled Comp Radiopharm       Date:  2016-08-31       Impact factor: 1.921

Review 5.  Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.

Authors:  C J Anderson; T J Wadas; E H Wong; G R Weisman
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-11-28       Impact factor: 2.346

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.